Filing excerpt
Stock Purchase Agreement, dated June 22, 2025, between Illumina, Inc. and Standard BioTools Inc.
sec.gov/Archives/edgar/data/1110803/000111080326000024/ilmn-20251228.htmRead the full source
Illumina10-K: Restructuring charge
Divesting assets via a stock purchase agreement with Standard BioTools Inc. in June 2025.
What happened
This strategic divestiture to Standard BioTools aims to streamline operations and focus on the core business. Such transactions require significant legal, financial, and IT effort to carve out assets, creating needs for M&A integration/divestiture support services and systems.
Source
Other signals in this filing (6)
- Chief commercial officer changeChief Commercial Officer Everett Cunningham departed Illumina on January 16, 2026.Chief commercial officer change
- SpinoffIllumina completed the spinoff of its GRAIL unit in June 2024, creating a separate company.Spinoff
- RestructuringMultiple executive departures in 2024-2026, including Chief Commercial OfficerRestructuring
- General counsel changeScott Davies is the new Chief Legal Officer, following the October 2024 departure of Charles Dadswell.General counsel change
- RestructuringSecured multiple new financing agreements in 2024-2025 to fund corporate changesRestructuring
- RestructuringIllumina divests a business unit to Standard BioTools Inc. in June 2025Restructuring
Extracted by Autobound
From the Signal API record- Signal
- 10-K: Restructuring charge
What this signalsFilings often name leadership changes, deals and spending plans.
- Period
- FY2025
- Fiscal year end
- 12/28
- Filed
- Feb 11, 2026
More from Illumina
- PatentsIllumina was granted a patent for substrates supporting sample quantification.Patents
- RedditA user experiencing periodic 10 bp peaks in RNA-seq data from an Illumina NovaSeq X Plus was informed by a self-identified Illumina employee that this pattern is a known artifact of...Reddit
- Web trafficillumina.com shows sustained decline with 3 consecutive months of decreases, down 24% overall to 635K.Web traffic
- GlassdoorLack of career growth and slow promotions reported by employeesGlassdoor
- Website changesIllumina expanded the catalog’s cross-selling and bundled-product presentation with additional “Frequently purchased together” and “View all bundles” calls to action.Website changes
- 8-KIllumina raises $300M in new debt to refinance existing notes maturing in September 2026.8-K
More 10-K signals at other companies
- SEC 10-KiPower Inc.iPower secured a $32M convertible note facility to fund new corporate purposesSEC 10-K
- SEC 10-KAmerican Vanguard CorporationAVD to reduce LA plant operations, incurring up to $10M in charges as part of transformation.SEC 10-K
- SEC 10-KBorealis Foods Inc.Auditors raise "Substantial Doubt" about company's ability to continue as a going concern.SEC 10-K
The full record
From the Signal API recordDetails
- CIK
- 1110803
- Accession number
- 0001110803-26-000024
- Timeframe
- Current year
- Filing year
- 2026
- Why it matters
- Vendor review likely
- Signal category
- Financial
Topics and mentions
Competitors
- Standard BioTools Inc.
Extraction
- Confidence
- High
- Relevance
- 80%
- Sentiment
- Neutral
- Detected
- Feb 17, 2026
- signal_type
sec-10k- signal_subtype
restructuringCharge
Use this data
Get every 10-K signal for Illumina and the companies you sell to, in the tools you already use.
Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Illumina this week?”
Send it to your own tools
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits
The API returns more than this page shows
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the API
Signal
signal_nameValue in the APIassociationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONHide the full JSONThe record on this page and the API request
GET /v1/signals/e8c2b8f4-5182-4dd8-9d20-16c135c46995 returns this record as JSON. POST /v1/companies/enrich returns every signal for illumina.com.
{
"signal_id": "e8c2b8f4-5182-4dd8-9d20-16c135c46995",
"signal_type": "sec-10k",
"signal_subtype": "restructuringCharge",
"detected_at": "2026-02-17T06:33:42.765+00:00",
"company": {
"name": "Illumina",
"domain": "illumina.com"
},
"data": {
"detail": "This strategic divestiture to Standard BioTools aims to streamline operations and focus on the core business. Such transactions require significant legal, financial, and IT effort to carve out assets, creating needs for M&A integration/divestiture support services and systems.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Divesting assets via a stock purchase agreement with Standard BioTools Inc. in June 2025.",
"excerpts": "Stock Purchase Agreement, dated June 22, 2025, between Illumina, Inc. and Standard BioTools Inc.",
"relevance": 0.8,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/ilmn-20251228.htm",
"filing_date": "2026-02-11",
"filing_year": 2026,
"fiscal_year_end": "12/28",
"sales_relevance": "Vendor review likely",
"signal_category": "financial",
"competitors_mentioned": [
"Standard BioTools Inc."
]
}
}
curl https://signals.autobound.ai/v1/signals/e8c2b8f4-5182-4dd8-9d20-16c135c46995 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"illumina.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.